PRS:3D打印聚己内酯模具成型的切块软骨显示出软骨细胞的再生潜力

2022-10-24 MedSci原创 MedSci原创

自体软骨移植经常在许多手术中用作支持材料。然而,对使用块状软骨移植物的关注,例如不可预测的吸收量、皮下可见性、皮肤暴露、有限的供体面积、移植物成形中遇到的困难以及由于明显弯曲而需要修正,限制了这些移植

自体软骨移植经常在许多手术中用作支持材料。然而,对使用块状软骨移植物的关注,例如不可预测的吸收量、皮下可见性、皮肤暴露、有限的供体面积、移植物成形中遇到的困难以及由于明显弯曲而需要修正,限制了这些移植物的使用。

使用切块软骨移植物的主要问题与移植物成形中遇到的困难和不可预测的移植物吸收有关。相关研究结果以“Evaluation of Diced Cartilage Grafts Shaped with Three-Dimensionally–Printed Bioresorbable Polycaprolactone Molds”为题,于2022年10月发表在《Plastic & Reconstructive Surgery》杂志。

原始文章

用制作成所需形状和形式的模具来塑造切块软骨移植物(比块状软骨移植物具有更高的生存能力,且并发症发生率更低。该研究旨在评估使用可生物降解的聚己内酯塑造自体切块软骨移植物对移植物持久性和存活力的影响。

图1 聚己内酯模具表征

图2块状软骨移植物、切块软骨移植物和用聚己内酯模具成型的切块软骨移植物

 

结果显示,用三维打印的聚己内酯模具成型的切块软骨显示出软骨细胞的再生潜力、血管化和胶原蛋白的产生增加。使用聚己内酯模具不会导致任何额外的炎症、纤维化或化生骨形成的风险。

图3 软骨细胞的再生能力

 

在这项研究中,已经表明三维打印的聚己内酯模具可以安全地用于成型软骨移植物。由于聚己内酯具有生物相容性和生物可降解性,并具有合适的机械强度和耐久性,因此聚己内酯可能是成形软骨块的理想异体塑料材料。

根据这项研究,借助于以更复杂的方式生产的模具,将有可能生产出可安全用于许多手术的混合移植物。切成丁的软骨移植物可以在聚己内酯模具的帮助下成型,用于需要软骨移植的手术,如隆鼻、鼻重建、耳廓重建和眶底骨折修复。

 

原始文章:

Canli M, Karasoy Yeşilada A, Ulağ S, Dobral A, Yalçin Ö, Gündüz O. Evaluation of Diced Cartilage Grafts Shaped with Three-Dimensionally-Printed Bioresorbable Polycaprolactone Molds. Plast Reconstr Surg. 2022;150(4):800e-809e. doi:10.1097/PRS.0000000000009572

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2095888, encodeId=ffdd209588859, content=转发学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Mon Oct 24 21:42:58 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095887, encodeId=91ba209588ef2, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Mon Oct 24 21:42:42 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095886, encodeId=72fa209588674, content=3D再造,成型意义重大, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Mon Oct 24 21:42:36 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095885, encodeId=f252209588544, content=学习受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Mon Oct 24 21:42:01 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095841, encodeId=d7d6209584193, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Mon Oct 24 17:40:28 CST 2022, time=2022-10-24, status=1, ipAttribution=)]
    2022-10-24 delianjihui

    转发学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2095888, encodeId=ffdd209588859, content=转发学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Mon Oct 24 21:42:58 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095887, encodeId=91ba209588ef2, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Mon Oct 24 21:42:42 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095886, encodeId=72fa209588674, content=3D再造,成型意义重大, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Mon Oct 24 21:42:36 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095885, encodeId=f252209588544, content=学习受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Mon Oct 24 21:42:01 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095841, encodeId=d7d6209584193, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Mon Oct 24 17:40:28 CST 2022, time=2022-10-24, status=1, ipAttribution=)]
    2022-10-24 delianjihui

    感谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2095888, encodeId=ffdd209588859, content=转发学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Mon Oct 24 21:42:58 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095887, encodeId=91ba209588ef2, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Mon Oct 24 21:42:42 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095886, encodeId=72fa209588674, content=3D再造,成型意义重大, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Mon Oct 24 21:42:36 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095885, encodeId=f252209588544, content=学习受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Mon Oct 24 21:42:01 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095841, encodeId=d7d6209584193, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Mon Oct 24 17:40:28 CST 2022, time=2022-10-24, status=1, ipAttribution=)]
    2022-10-24 delianjihui

    3D再造,成型意义重大

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2095888, encodeId=ffdd209588859, content=转发学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Mon Oct 24 21:42:58 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095887, encodeId=91ba209588ef2, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Mon Oct 24 21:42:42 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095886, encodeId=72fa209588674, content=3D再造,成型意义重大, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Mon Oct 24 21:42:36 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095885, encodeId=f252209588544, content=学习受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Mon Oct 24 21:42:01 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095841, encodeId=d7d6209584193, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Mon Oct 24 17:40:28 CST 2022, time=2022-10-24, status=1, ipAttribution=)]
    2022-10-24 delianjihui

    学习受益

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2095888, encodeId=ffdd209588859, content=转发学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Mon Oct 24 21:42:58 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095887, encodeId=91ba209588ef2, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Mon Oct 24 21:42:42 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095886, encodeId=72fa209588674, content=3D再造,成型意义重大, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Mon Oct 24 21:42:36 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095885, encodeId=f252209588544, content=学习受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5281475204, createdName=delianjihui, createdTime=Mon Oct 24 21:42:01 CST 2022, time=2022-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095841, encodeId=d7d6209584193, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Mon Oct 24 17:40:28 CST 2022, time=2022-10-24, status=1, ipAttribution=)]
    2022-10-24 医鸣惊人

    认真学习了

    0

拓展阅读

PLAST RECONSTR SURG:肋软骨移植治疗半侧颜面短小畸形长期效果揭秘:外科医生24年研究经验总结

本研究发现对于Pruzansky-Kaban IIB /III型半侧颜面短小畸形患者,肋软骨移植能够显著改善短期的下颌和面部对称度。然而,患侧下颌生长行为固有的局限性可能会限制面部对称性的维持。

小耳症患者双侧肋软骨之间的差异

在耳廓重建手术中,肋软骨是制造耳廓框架的理想介质。

术式创新!肋软骨弹簧移植矫正成人唇裂鼻畸形

因为软骨的脆弱性和紧密收缩的软组织易塌陷,唇裂鼻畸形的后期矫正仍然是一个挑战。作者描述了肋骨软骨弹簧移植的新技术,将鼻小柱和下外侧软骨作为一块,用于唇裂鼻畸形的后期矫正,以获得对称、美观、更持久和可接

鼻整形移植物材料主要有哪些?区别是什么?

本资料旨在向且仅向医疗专业人士提供信息。如果您不是医疗专业人士,请勿阅读或传播其中的内容。

隆胸术后肋骨移植鼻成形术的联合整形手术选择什么切口?

联合整形手术逐渐增多,都有乳房与肋软骨鼻整形需求的患者,越来越倾向于同时做手术。联合整形手术对患者有利,只需1次麻醉,减少了手术次数。